Jpmorgan Chase & CO Crispr Therapeutics Ag Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Jpmorgan Chase & CO holds 329,069 shares of CRSP stock, worth $16.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

329,069

Previous 392,750 16.21%

Holding current value

$16.6 Million

Previous $26.8 Million 33.61%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$51.17 - $68.18 $3.26 Million - $4.34 Million	-63,681 Reduced 16.21%	329,069 $17.8 Million
Q1 2024 May 10, 2024	SELL	$60.67 - $89.12 $4.28 Million - $6.28 Million	-70,520 Reduced 15.22%	392,750 $26.8 Million
Q4 2023 Feb 12, 2024	SELL	$38.62 - $72.18 $2.21 Million - $4.13 Million	-57,159 Reduced 10.98%	463,270 $29 Million
Q3 2023 Nov 14, 2023	SELL	$45.39 - $59.0 $1.41 Million - $1.83 Million	-30,966 Reduced 5.62%	520,429 $23.6 Million
Q2 2023 Aug 11, 2023	SELL	$43.47 - $67.77 $1.36 Million - $2.12 Million	-31,269 Reduced 5.37%	551,395 $31 Million
Q1 2023 May 18, 2023	BUY	$41.0 - $56.12 $1.79 Million - $2.46 Million	43,757 Added 8.12%	582,664 $26.4 Million
Q1 2023 May 11, 2023	SELL	$41.0 - $56.12 $2.08 Million - $2.85 Million	-50,716 Reduced 8.6%	538,907 $24.4 Million
Q4 2022 Feb 13, 2023	SELL	$39.19 - $65.67 $911,833 - $1.53 Million	-23,267 Reduced 3.8%	589,623 $24 Million
Q3 2022 Nov 14, 2022	SELL	$61.1 - $83.78 $3.07 Million - $4.2 Million	-50,170 Reduced 7.57%	612,890 $40.1 Million
Q2 2022 Aug 11, 2022	BUY	$43.23 - $73.83 $712,776 - $1.22 Million	16,488 Added 2.55%	663,060 $40.3 Million
Q1 2022 May 11, 2022	SELL	$53.19 - $79.24 $6.67 Million - $9.93 Million	-125,327 Reduced 16.24%	646,572 $40.6 Million
Q4 2021 Feb 10, 2022	BUY	$70.09 - $111.29 $8.92 Million - $14.2 Million	127,313 Added 19.75%	771,899 $58.5 Million
Q3 2021 Nov 12, 2021	BUY	$110.2 - $156.64 $71 Million - $101 Million	644,586 New	644,586 $72.2 Million

Others Institutions Holding CRSP

# of Institutions

505

Shares Held

57.3M

Call Options Held

1.74M

Put Options Held

1.84M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.95B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Crispr Therapeutics Ag Transaction History